188 related articles for article (PubMed ID: 8237075)
1. [Antihypertensive therapy and vascular wall protection with special reference to calcium antagonists].
Faulhaber HD
Z Arztl Fortbild (Jena); 1993; 87(9 Suppl 5):1-5. PubMed ID: 8237075
[No Abstract] [Full Text] [Related]
2. Calcium-channel antagonists: mechanisms of action, vascular selectivities, and clinical relevance.
Triggle DJ
Cleve Clin J Med; 1992; 59(6):617-27. PubMed ID: 1330367
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers and atherosclerosis.
Sowers JR
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):3-9. PubMed ID: 2220798
[TBL] [Abstract][Full Text] [Related]
4. From channels to cats: an overview of isradipine pharmacology.
Rüegg UT; Hof RP
Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635
[No Abstract] [Full Text] [Related]
5. [Evaluation of anti-atheromatous properties of calcium channel inhibitors].
Drici MD; Coccoz F; Morand P; Lapalus P
Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():161-5. PubMed ID: 1285697
[TBL] [Abstract][Full Text] [Related]
6. [Involvement of calcium channels in the pathogenesis of hypertension].
Murakami M; Iijima T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():152-5. PubMed ID: 15171360
[No Abstract] [Full Text] [Related]
7. [Role of calcium antagonists in the treatment of arterial hypertension].
Velasco M; Negrín C
Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of action of calcium antagonists].
Stimpel M; Neyses L
Schweiz Rundsch Med Prax; 1985 May; 74(19):483-90. PubMed ID: 2409579
[No Abstract] [Full Text] [Related]
9. [Calcium antagonists. Pharmacology and clinical pharmacology].
Grobecker H
Med Monatsschr Pharm; 1994 May; 17(5):130-9. PubMed ID: 8022361
[No Abstract] [Full Text] [Related]
10. Effects of calcium on vascular smooth muscle tone.
Morgan KG; Suematsu E
Am J Hypertens; 1990 Dec; 3(12 Pt 2):291S-298S. PubMed ID: 2078315
[TBL] [Abstract][Full Text] [Related]
11. Introduction: the role of calcium antagonists.
van Zwieten PA
J Hypertens Suppl; 1998 Oct; 16(6):S1-2. PubMed ID: 9856376
[No Abstract] [Full Text] [Related]
12. Effect of antihypertensive treatment on small artery remodeling in hypertension.
Schiffrin EL
Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
[TBL] [Abstract][Full Text] [Related]
13. Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension.
Touyz RM
Med Hypotheses; 1991 Oct; 36(2):140-1. PubMed ID: 1664038
[TBL] [Abstract][Full Text] [Related]
14. [The role of calcium antagonists in the treatment of hypertension].
Rosenthal J; Völger KD
Internist (Berl); 1991 Dec; 32(12):674-89. PubMed ID: 1783511
[No Abstract] [Full Text] [Related]
15. [Studies on the mechanisms of the antiatherogenic effect of Ca-antagonists].
Birou S
Igaku Kenkyu; 1988 Apr; 58(2):77-84. PubMed ID: 3245408
[No Abstract] [Full Text] [Related]
16. [Clinical pharmacology of calcium antagonists].
Tamargo J
Rev Esp Cardiol; 1994 Dec; 47(12):824-35. PubMed ID: 7855378
[No Abstract] [Full Text] [Related]
17. A symposium: The calcium ion, cardiac myocyte and vascular smooth muscle in hypertension and its treatment. March 27-29, Nassau, the Bahamas.
Am J Cardiol; 1987 Jan; 59(2):1A-121A. PubMed ID: 2433924
[No Abstract] [Full Text] [Related]
18. [Angiotensin II receptor antagonists. Clinical relevance].
Scholze J
Internist (Berl); 1996 Jun; 37(6):636-42. PubMed ID: 8767999
[No Abstract] [Full Text] [Related]
19. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
Xiao HJ; Liu JH
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
[TBL] [Abstract][Full Text] [Related]
20. The antiatherosclerotic effects of calcium antagonists.
Paoletti R; Bernini F; Corsini A; Soma MR
J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S6-10. PubMed ID: 8852538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
